JP2013543874A5 - - Google Patents

Download PDF

Info

Publication number
JP2013543874A5
JP2013543874A5 JP2013540214A JP2013540214A JP2013543874A5 JP 2013543874 A5 JP2013543874 A5 JP 2013543874A5 JP 2013540214 A JP2013540214 A JP 2013540214A JP 2013540214 A JP2013540214 A JP 2013540214A JP 2013543874 A5 JP2013543874 A5 JP 2013543874A5
Authority
JP
Japan
Prior art keywords
plga
acid
weight
microsphere composition
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013540214A
Other languages
English (en)
Japanese (ja)
Other versions
JP6006225B2 (ja
JP2013543874A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2011/001958 external-priority patent/WO2012068783A1/en
Publication of JP2013543874A publication Critical patent/JP2013543874A/ja
Publication of JP2013543874A5 publication Critical patent/JP2013543874A5/ja
Application granted granted Critical
Publication of JP6006225B2 publication Critical patent/JP6006225B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013540214A 2010-11-25 2011-11-25 ロチゴチン、その誘導体、又はロチゴチン若しくはその誘導体の薬学的に許容可能な塩の組成物 Active JP6006225B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201010576447.5 2010-11-25
CN201010576447 2010-11-25
PCT/CN2011/001958 WO2012068783A1 (en) 2010-11-25 2011-11-25 Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015163527A Division JP6067803B2 (ja) 2010-11-25 2015-08-21 ロチゴチン、その誘導体、又はロチゴチン若しくはその誘導体の薬学的に許容可能な塩の組成物

Publications (3)

Publication Number Publication Date
JP2013543874A JP2013543874A (ja) 2013-12-09
JP2013543874A5 true JP2013543874A5 (enExample) 2014-11-13
JP6006225B2 JP6006225B2 (ja) 2016-10-12

Family

ID=46145374

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013540214A Active JP6006225B2 (ja) 2010-11-25 2011-11-25 ロチゴチン、その誘導体、又はロチゴチン若しくはその誘導体の薬学的に許容可能な塩の組成物
JP2015163527A Active JP6067803B2 (ja) 2010-11-25 2015-08-21 ロチゴチン、その誘導体、又はロチゴチン若しくはその誘導体の薬学的に許容可能な塩の組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015163527A Active JP6067803B2 (ja) 2010-11-25 2015-08-21 ロチゴチン、その誘導体、又はロチゴチン若しくはその誘導体の薬学的に許容可能な塩の組成物

Country Status (14)

Country Link
US (1) US9265835B2 (enExample)
EP (1) EP2642993B1 (enExample)
JP (2) JP6006225B2 (enExample)
KR (1) KR101481643B1 (enExample)
CN (1) CN103458895B (enExample)
AU (1) AU2011334494B2 (enExample)
BR (1) BR112013012726B1 (enExample)
CA (1) CA2816288C (enExample)
ES (1) ES2572948T3 (enExample)
MY (1) MY165003A (enExample)
PH (1) PH12013500923A1 (enExample)
PL (1) PL2642993T3 (enExample)
RU (1) RU2589700C2 (enExample)
WO (1) WO2012068783A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8682462B2 (en) 2011-08-13 2014-03-25 Colin M. Leonard Systems and methods for dynamic audio processing
US11074031B1 (en) 2016-09-06 2021-07-27 Colin Leonard Systems and methods for dynamic audio processing
EP2559435A1 (en) 2011-08-19 2013-02-20 UCB Pharma GmbH Rotigotine in the treatment of hemispatial neglect, stroke and deficits following stroke
KR101558042B1 (ko) * 2012-07-05 2015-10-07 에스케이케미칼주식회사 로티고틴을 함유한 경피흡수제제
AU2014375268B2 (en) * 2013-12-31 2019-11-14 Pb & B Sa Controlled release fatty acid compositions for use in body reconstruction and body-shaping
CN105310974B (zh) * 2014-08-01 2019-08-23 山东绿叶制药有限公司 罗替戈汀及其衍生物或其药用盐的植入剂
CN106474070B (zh) * 2015-08-26 2020-03-17 四川科伦药物研究院有限公司 一种克服停滞期、恒速释放疏水性药物的微球及制备方法
CN105963253A (zh) * 2016-06-19 2016-09-28 朱武欣 一种罗替戈汀长效水性混悬型注射剂
ES2855976T3 (es) 2016-07-21 2021-09-27 Shandong luye pharmaceutical co ltd Behenato de rotigotina y procedimiento de fabricación y aplicación del mismo
WO2018045000A1 (en) 2016-08-30 2018-03-08 Dow Agrosciences Llc Picolinamides as fungicides
WO2018096560A1 (en) 2016-11-23 2018-05-31 Cipla Limited Long acting depot formulation for the continuous dopaminergic stimulation
KR102089737B1 (ko) * 2017-11-01 2020-03-16 한국화학연구원 에씨탈로프람을 함유한 미립구형 서방출 주사제 및 그의 제조방법
KR102181231B1 (ko) * 2018-11-22 2020-11-20 주식회사 메디포럼제약 로티고틴 함유 고분자 미립자의 제조방법
CN115484935A (zh) * 2020-02-14 2022-12-16 G2G生物公司 包括含有glp-1类似物或其药学上可接受的盐的缓释微球的药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718986D0 (en) * 1997-09-09 1997-11-12 Danbiosyst Uk Controlled release microsphere delivery system
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
CA2574085C (en) * 2004-07-16 2014-02-11 Oakwood Laboratories, L.L.C. Gonadotropin releasing hormone antagonists
US8691277B2 (en) 2004-09-21 2014-04-08 Shandong Luye Pharmaceutical Co., Ltd. Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof
CN1762495B (zh) * 2004-09-21 2011-04-06 山东绿叶制药有限公司 含有多巴胺受体激动剂类药物的长效缓释制剂及其制备工艺
JP5222550B2 (ja) 2007-12-27 2013-06-26 財團法人工業技術研究院 徐放性組成物およびその製造方法

Similar Documents

Publication Publication Date Title
JP2013543874A5 (enExample)
EP2968320B1 (en) Organic compounds
RU2013128430A (ru) Композиции ротиготина, их производных или фармацевтически приемлемых солей ротиготина или их производных
EP2982367B1 (en) Pharmaceutical composition for parenteral administration, containing donepezil
JP6002290B2 (ja) 水難溶性薬物含有徐放性微小粒子及びその製造方法
AU2015242738B2 (en) Amorphous solid dispersion comprising taxane, tablet comprising the same, and method for preparing the same
WO2018223894A1 (zh) 一种长效缓释药物制剂及其制备方法
KR20160093055A (ko) 신규한 방법
JP2016094411A5 (enExample)
JP2015044823A5 (enExample)
EA201401346A1 (ru) Технология приготовления имплантируемой формы рисперидона или палиперидона
JP2015520197A5 (enExample)
JP6781717B2 (ja) 駆虫薬の大環状ラクトンを含むミクロスフェア
WO2012092339A3 (en) The design of hydrolytically releasable prodrugs for sustained release nanoparticle formulations
JP2014534197A5 (enExample)
JP2008513524A (ja) ドーパミン受容体アゴニストを含む長時間作用する持続放出製剤、及びそれらの製造方法
WO2022228585A1 (zh) 一种左旋千金藤啶碱缓释微球及其制备方法
JP2008513524A5 (enExample)
CN103599074A (zh) 一种伊潘立酮缓释微球及其制备方法
Wang et al. Comparative studies on the properties of glycyrrhetinic acid-loaded PLGA microparticles prepared by emulsion and template methods
JP2025509390A (ja) カリプラジン又はその塩を含むデポシステム
KR102235011B1 (ko) 약물 함유 plga 미립구 및 그의 제조방법
Blanco-Prıeto et al. In vitro evaluation of gentamicin released from microparticles
JP2012500788A5 (enExample)
US12233165B2 (en) Microsphere formulations comprising ketamine and methods for making and using the same